9874
aliphatic aldehydes used in our study gave rise to a significantly greater proportion of the
benzimidazolium side-products compared with the benzaldehydes. The product ratios determined
1
by HPLC and shown in Table 1 are consistent with those observed in the H NMR spectra.
In summary, we have demonstrated that benzimidazoles can be efficiently prepared from a
support-bound o-nitroaniline using a ‘one-pot’ reduction–cyclisation method. This approach has
provided the shortest solid phase synthesis of benzimidazoles to date. Since a wide range of amines
and aldehydes are commercially available, a large number of benzimidazoles can be easily prepared
using this method. It is worth noting that this ‘one-pot’ method has also been applied to other
1
1b
11c
Lantern products (e.g. Rink amide and HMP ) and commercially available Wang resins to
produce benzimidazoles in excellent purity.
Acknowledgements
The authors wish to acknowledge the assistance of Heather Patsiouras and Michael FitzGerald
in obtaining mass spectra.
References
1
2
3
4
5
6
7
8
9
. Phillips, G. B.; Wei, G. P. Tetrahedron Lett. 1996, 37, 4887–4890.
. Lee, J.; Gauthier, D.; Rivero, R. A. Tetrahedron Lett. 1998, 39, 201–204.
. Mayer, J. P.; Lewis, G. S.; McGee, C.; Bankaitis-Davis, D. Tetrahedron Lett. 1998, 39, 6655–6658.
. Tumelty, D.; Schwarz, M. K.; Needels, M. C. Tetrahedron Lett. 1998, 39, 7467–7470.
. Sun, Q.; Yan, B. Bioorg. Med. Chem. Lett. 1998, 8, 361–364.
. Huang, W.; Scarborough, R. M. Tetrahedron Lett. 1999, 40, 2665–2668.
. Tumelty, D.; Schwarz, M. K.; Cao, K.; Needels, M. C. Tetrahedron Lett. 1999, 40, 6185–6188.
. Smith, J. M.; Krchnak, V. Tetrahedron Lett. 1999, 40, 7633–7636.
. Smith, J. M.; Gard, J.; Cummings, W.; Kanizsai, A.; Krchnak, V. J. Comb. Chem. 1999, 1, 368–370.
1
1
1
1
1
1
1
0. Morales, G. A.; Corbett, J. W.; DeGrado, W. F. J. Org. Chem. 1998, 63, 1172–1177.
1. (a) Product code: SPPSDCLM. (b) Product code: SPPSDRAM. (c) Product code: SPPSDHMP.
2. Wei, G. P.; Phillips, G. B. Tetrahedron Lett. 1998, 39, 179–182.
3. Pan, P.-C.; Sun, C.-M. Tetrahedron Lett. 1999, 40, 6443–6446.
4. Lee, J.; Murray, W. V.; Rivero, R. A. J. Org. Chem. 1997, 62, 3874–3879.
5. Mataka, S.; Shimojyo, Y.; Hashimoto, I.; Tashiro, M. Liebigs Ann. 1995, 1823–1825.
6. A typical procedure is as follows: each o-nitroaniline D-series Lantern 4 is treated with 0.5 mL of a solution of
aldehyde (0.15 M, 2 molar equivalents) and SnCl ·2H O (0.75 M, 10 molar equivalents) in DMF at 60°C for 3
2
2
h. The reaction mixture was allowed to cool briefly and the reagent solution decanted. The Lanterns were washed
with DMF (3×3 min) and DCM (3×3 min), and air dried. Each Lantern was cleaved in a polypropylene tube with
0
.7 mL of 20% TFA/DCM for 1 h. The Lantern was removed and the cleavage solution evaporated. The residue
was dissolved in 90% CH CN/H O for HPLC and MS analysis.
3
2
1
1
7. For example, compound 9: H NMR (400 MHz, CDCl ) l 8.58, (d, J=1.2 Hz, H ), 8.13 (dd, J =1.2 Hz, J =8.4
3 a 1 2
Hz, H ), 8.00 (s, H ), 7.98 (d, J=8.4 Hz, H ), 7.87 (d, J=8.0 Hz, H ), 7.75 (t, J=8.0 Hz, H ), 7.54 (d, J=8.4
b
d
g
e
f
Hz, H ), 4.43 (t, J=7.6 Hz, NCH CH CH ), 1.90 (m, NCH CH CH ), 0.91 (t, J=7.6 Hz, NCH CH CH ).
c
2
2
3
2
2
3
2
2
3